Adverse reactions | n(%) | Adverse reactions | n(%) | ||
---|---|---|---|---|---|
Granulocyte reduction | 13(39.4) | Hypertension | 22(66.7) | ||
I | II | 12(36.4) | I | II | 17(51.5) |
III | IV | 1(3.0) | III | IV | 5(15.2) |
Anemia | 8(24.2) | Proteinuria | 9(27.3) | ||
I | II | 8(24.2) | I | II | 9(27.3) |
III | IV | 0 | III | IV | 0 |
Thrombocytopenia | 1(3.0) | Hand-foot syndrome | 10(30.3) | ||
I | II | 0 | I | II | 7(21.2) |
III | IV | 1(3.0) | III | IV | 3(9.1) |
Liver damage | 3(9.1) | Weak | 5(15.2) | ||
I | II | 3(9.1) | I | II | 5(15.2) |
III | IV | 0 | III | IV | 0 |